Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Michele T Hu"'
Autor:
Michael Lawton, Inga Liepelt-Scarfone, Rejko Krüger, Michele T Hu, Christine Lo, Charlotte Woodward, Francesca Bowring, Jessica Welch, Patricia Sulzer, Anne-Marie Hanff
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/12c311c829134c09bb37d22325e86475
Autor:
Thomas Foltynie, Rachael Hunter, Lynn Rochester, Dilan Athauda, Patricia Limousin, Alexa King, Simon Skene, Kashfia Chowdhury, Camille B Carroll, Huw Morris, Michele T Hu, Monty Silverdale, Rachel Gibson, Marisa Chau, Christine Lo, Nirosen Vijiaratnam, Christine Girges, Grace Auld, Kate Maclagan, Steve Hibbert, Gordon W Duncan, Ray Chaudhuri, Silvia Del Din, Alison J Yarnall, John Dickson, Vincenzo Libri
Publikováno v:
BMJ Open, Vol 11, Iss 5 (2021)
Introduction Parkinson’s disease (PD) is a common neurodegenerative disorder with substantial morbidity. No disease-modifying treatments currently exist. The glucagon like peptide-1 receptor agonist exenatide has been associated in single-centre st
Externí odkaz:
https://doaj.org/article/747e573c62344e5b81c9220c10131898
Publikováno v:
eLife, Vol 9 (2020)
We can be motivated when reward depends on performance, or merely by the prospect of a guaranteed reward. Performance-dependent (contingent) reward is instrumental, relying on an internal action-outcome model, whereas motivation by guaranteed reward
Externí odkaz:
https://doaj.org/article/5cdbd7e442d94300bf595168737d5bf6
Autor:
Ricarda A L Menke, Michael Lawton, Thomas R Barber, Johannes C Klein, Konrad Szewczyk-Krolikowski, Michele T Hu, Michal Rolinski, Ludovica Griffanti, Samuel G Evetts, Faye Begeti, Marie Crabbe, Jane Rumbold, Richard Wade-Martins
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/6b7c4018c7df46b485dce3ac2a5f9b1c
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
ObjectivesRoutine exercise is thought to be among the only disease-modifying treatments for Parkinson’s disease; however, patients’ progressive loss of physical ability limits its application. Therefore, we sought to investigate whether a ketone
Externí odkaz:
https://doaj.org/article/870060d8414a4f8f8258883705f26b8b
Publikováno v:
Frontiers in Nutrition, Vol 6 (2019)
Parkinson's disease, a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, is strongly associated with the death of dopaminergic neurons in the brain's substantia nigra. Although dopamine replacement therapy temporar
Externí odkaz:
https://doaj.org/article/5c9f65bc74254fc6b7e4e16d99c11151
Autor:
Michael Lawton, Yoav Ben-Shlomo, Apostolos Gkatzionis, Michele T. Hu, Donald Grosset, Kate Tilling
Identifying factors that are causes of disease progression, especially in neurodegenerative diseases, is of considerable interest. Disease progression can be described as a trajectory of outcome over time - for example, a linear trajectory having bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92f1fc677eb807f90631d37bbe3f9b31
https://doi.org/10.1101/2023.04.27.23289203
https://doi.org/10.1101/2023.04.27.23289203
Autor:
Sophie Lawrie, Shelly Coe, Maedeh Mansoubi, Jessica Welch, Jamil Razzaque, Michele T. Hu, Helen Dawes
Publikováno v:
Journal of the American Nutrition Association. 42:393-402
Evidence-based treatment for nonmotor symptoms in Parkinson's disease (PD) is limited. Lifestyle-based improvements including dietary changes may be a potential management strategy. The intent of this research was to investigate the extent to which 3
Autor:
Hugo J.R. Fernandes, Elizabeth M. Hartfield, Helen C. Christian, Evangelia Emmanoulidou, Ying Zheng, Heather Booth, Helle Bogetofte, Charmaine Lang, Brent J. Ryan, S. Pablo Sardi, Jennifer Badger, Jane Vowles, Samuel Evetts, George K. Tofaris, Kostas Vekrellis, Kevin Talbot, Michele T. Hu, William James, Sally A. Cowley, Richard Wade-Martins
Publikováno v:
Stem Cell Reports, Vol 6, Iss 3, Pp 342-356 (2016)
Heterozygous mutations in the glucocerebrosidase gene (GBA) represent the strongest common genetic risk factor for Parkinson's disease (PD), the second most common neurodegenerative disorder. However, the molecular mechanisms underlying this associat
Externí odkaz:
https://doaj.org/article/20acb6da0a224454831f8f80ba1147cd